Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation

Idiopathic pulmonary fibrosis (IPF) is a serious progressive and irreversible lung disease with unknown etiology and few treatment options. This disease was once thought to be a chronic inflammatory-driven process, but it is increasingly recognized that the epithelial–mesenchymal transition (EMT) co...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chen, Y-L, Zhang, X, Bai, J, Gai, L, Ye, X-L, Zhang, L, Xu, Q, Zhang, Y-X, Xu, L, Li, H-P, Ding, X
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 2013
Subjects:	Original Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3698540/ https://ncbi.nlm.nih.gov/pubmed/23764846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2013.154
Tags:	Add Tag No Tags, Be the first to tag this record!

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation

Similar Items